Tiziana Life Sciences Ltd (TLSA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tiziana Life Sciences Ltd

    NASDAQ: TLSA · Real-Time Price · USD
    1.62
    -0.04 (-2.41%)
    At close: Sep 08, 2025, 3:59 PM
    1.63
    0.62%
    After-hours: Sep 08, 2025, 07:58 PM EDT

    Tiziana Life Sciences Ltd Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a
    Operating Income
    		 -17.98M -14.59M -27.37M
    Interest Income
    		 1.15M n/a n/a
    Pretax Income
    		 -17.24M -15.4M -26.66M
    Net Income
    		 -17.69M -15.4M -23.42M
    Selling & General & Admin
    		 n/a n/a 855K
    Research & Development
    		 8.11M 12.96M 13.21M
    Other Expenses
    		 9.87M 1.63M 13.31M
    Operating Expenses
    		 17.98M 14.59M 27.37M
    Interest Expense
    		 10K 7K 176K
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 17.98M 14.59M 27.37M
    Income Tax Expense
    		 449K n/a -3.24M
    Shares Outstanding (Basic)
    		 50.76M 50.76M 48.97M
    Shares Outstanding (Diluted)
    		 50.76M 50.76M 48.97M
    EPS (Basic)
    		 -0.34 -0.3 -0.48
    EPS (Diluted)
    		 -0.34 -0.3 -0.48
    EBITDA
    		 -17.14M -15.34M -26.34M
    EBIT
    		 -17.23M -15.39M -26.48M
    Depreciation & Amortization
    		 96K 51K 141K

    Add to Watchlist